Diagnosis: Incomplete Kawasaki Disease
This child most likely has incomplete Kawasaki disease, and urgent echocardiography with immediate intravenous immunoglobulin (IVIG) administration is critical to prevent coronary artery aneurysms. 1
Clinical Reasoning
Why Kawasaki Disease Fits This Presentation
Incomplete Kawasaki disease should be considered in any child with unexplained fever ≥5 days plus 2–3 principal clinical features, which this patient clearly demonstrates: urticarial rash (polymorphous exanthema), facial edema (oral-cavity changes/facial swelling), and abdominal pain. 1
The urticarial-type rash qualifies as the polymorphous exanthema characteristic of Kawasaki disease and is commonly mistaken for a drug reaction or simple allergic urticaria—a critical diagnostic pitfall. 1
Facial edema (puffy face) represents one of the principal clinical features related to oral-cavity and mucosal changes seen in Kawasaki disease. 1
Abdominal pain is a well-recognized gastrointestinal manifestation of Kawasaki disease and can mimic an acute surgical abdomen, potentially leading to misdiagnosis. 1
Elevated white blood cell count (leukocytosis) is a characteristic laboratory finding and forms part of the Harada risk-score criteria for Kawasaki disease. 1
Laboratory Findings Consistent with Kawasaki Disease
The urine albumin (30 mg/dL proteinuria) and ketonuria (160) are explained by sterile pyuria, which is characteristic of Kawasaki disease and reflects systemic inflammation affecting multiple organs. 1
Hypoalbuminemia is a common finding in acute Kawasaki disease due to capillary leak and systemic inflammation. 1
Why Other Diagnoses Are Less Likely
Urticarial vasculitis is excluded because individual wheals in ordinary urticaria last 2–24 hours and resolve without scarring, whereas urticarial vasculitis lesions persist for days and leave hyperpigmentation or bruising. 2 This patient's presentation does not describe persistent wheals beyond 24 hours.
IgA vasculitis (Henoch-Schönlein purpura) is less likely because the classic presentation requires palpable purpura (not urticaria) on the lower extremities, and 95% of patients present with this purpuric rash. 3, 4 The urticarial rash described here does not match the palpable purpura pattern.
Simple allergic urticaria does not explain the constellation of fever, abdominal pain, facial edema, leukocytosis, and proteinuria—these systemic features point to a vasculitic process. 2
Immediate Management Algorithm
Step 1: Urgent Cardiac Evaluation
Order echocardiography immediately because coronary artery abnormalities (perivascular brightness, ectasia, lack of tapering) can be visible before frank aneurysm formation, and young children are at particularly high risk for coronary complications. 1
Look for additional echocardiographic findings that support the diagnosis: decreased left-ventricular contractility, mitral regurgitation, and pericardial effusion. 1
Step 2: Administer IVIG Without Delay
Administer intravenous immunoglobulin (IVIG) within the first 10 days of illness to reduce the risk of coronary artery aneurysms, which occur in 15–25% of untreated children. 1
Do not delay IVIG while treating only the rash with antihistamines—this is a critical error that can lead to irreversible cardiac damage. 1
Step 3: Supportive Laboratory Work-Up
Obtain complete blood count, ESR or CRP, liver transaminases, and albumin to document the degree of systemic inflammation and support the diagnosis. 1
Platelet count may be normal in the acute phase but thrombocytosis typically develops in the subacute phase. 1
Mild anemia (reduced hemoglobin/hematocrit) is expected during acute illness. 1
Critical Pitfalls to Avoid
Do not dismiss the urticarial rash as a simple allergic reaction or drug eruption—recognizing it as part of the primary disease prevents catastrophic mismanagement. 1
Do not attribute the abdominal pain to a surgical emergency without considering Kawasaki disease when other features (fever, rash, facial swelling, leukocytosis) are present. 1
Incomplete Kawasaki disease is more common in infants ≤6 months, but older children can also present with fewer than the full five principal clinical features; maintain a high index of suspicion when fever ≥5 days, systemic inflammation, and no alternative diagnosis are present. 1
Antihistamines alone are insufficient and dangerous—they may temporarily mask symptoms while coronary damage progresses. 1
Follow-Up and Monitoring
Repeat echocardiography at 2 weeks and 6–8 weeks after diagnosis to monitor for late-developing coronary abnormalities. 1
Monitor for IVIG resistance (persistent or recurrent fever ≥36 hours after completion of the first IVIG dose), which occurs in 10–20% of patients and requires a second IVIG dose or adjunctive therapy. 1